A) shows the top view and B) the side view of the inspection platform in use (Wilco AG, Rigackerstraße 11, 5610 Wohlen - Quelle: Wilco AG

Case Study with a TDLAS-based Semi-automated Media Fill Inspection Platform

Media fills are process simulations imitating the aseptic filling procedure with microbial culture medium instead of the liquid drug product. The visual inspection on turbidity of fill-finished media fills represents the control of filling line asepticity and is a rather time-consuming activity. Former studies have discussed the feasibility of automating this visual media fill inspection by tunable diode laser absorption spectroscopy (TDLAS) benchtop devices. The idea of using TDLAS was based on determining non-invasively CO2 and O2 headspace concentration changes as indicator for microbial growth in test samples. Since the results from former studies were highly promising in terms of detecting contaminated media fill samples, a follow-up case study was performed with a semi-automated system provided by Wilco AG, enabling high-throughput detection (100 vials per minute). The study delivered very promising results in terms of media fill inspection automation and gives evidence for a more efficient design of the entire media fill process. Therefore, an implementation in aseptic drug product manufacturing is highly recommendable.

https://www.ecv.de/beitrag/pharmind/Case_Study_with_a_TDLAS-based_Semi-automated_Media_Fill_Inspection_Platform

PHARMA-IMPACT schreibt über Bringt Entscheider weiter!

Die beiden Zeitschriften pharmind und Tech4Pharma (vormals TechnoPharm) publizieren exklusive Fachbeiträge für die international agierende Pharmaindustrie. Die Artikel werden von einem Redaktionsbeirat im Review-Verfahren nach qualitativen Maßstäben geprüft und ausgewählt. Daraus entsteht ein Themenspektrum, so einzigartig und vielseitig wie die Branche selbst. Unter der Marke Pharma-Impact bündelt der ECV Editio Cantor Verlag die unterschiedlichen inhaltlichen Orientierungen der Titel (pharmazeutisch / technisch) zu einem attraktiven Gesamtangebot für alle Entscheider, Experten und Multiplikatoren aus der Pharma- und Zulieferindustrie.

Artikelsammlung ansehen